Trades on 5 secondary markets

Mammoth Biosciences

Mammoth Biosciences is a genetic medicines company co-founded by CRISPR co-inventor Jennifer Doudna, developing in vivo gene-editing therapeutics and CRISPR-based diagnostics. The company discovers and engineers novel CRISPR systems and proteins to overcome delivery challenges in genetic medicine, w

minimal 6.8 / 100 0 APIs View provider profile →

Company Biotechnology CRISPR Gene Editing Genetic Medicine Diagnostics

Mammoth Biosciences is an API provider whose private shares are listed on 5 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market, Augment.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing → A Augment View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.